Navigation Links
FDA Diminish Hopes On ‘Female Viagra

US authorities are pouring cold water on hopes for a new drug to treat women with //low sexual desire.

The Food and Drug Administration (FDA) wants more studies to be done on the Intrinsa patch made by Procter & Gamble in order to find out what long-term side effects the drug may induce, the Los Angeles Times reported.

Intrinsa has been called "female Viagra" as it promises to restore healthy sexual appetites to women struggling with low desire.

Though experts say female sexuality is more complex than male, and affected more deeply by mood, self-esteem and the relationship, new studies of Intrinsa showed that the drug boosts desire by delivering small doses of testosterone through a woman's skin, thereby boosting the level of the male sex hormone in the bloodstream.

According to some estimates, the drug could help 11 million US women who are thought to suffer from a condition known in medical circles as hypoactive sexual desire disorder, or HSDD.

But though it took only six months for the FDA to approve Viagra for enhancing male libido, there is no approval in sight for the female version.

Acknowledging the "huge demand" that would probably come with approval, panel members worried aloud that long-term use by millions of women might increase the rates of breast cancer, heart disease and stroke.

The concerns were increased by the belated recognition that hormone replacement therapy, used for years to soften the effects of menopause, was linked to a significant increase in heart disease, breast cancer and strokes.

The cautious approach is also because of mounting concern over long-term safety of new drugs prompted by the discovery last December of the potentially fatal side effects associated with the anti-arthritis drug Vioxx.

Last December, just weeks after Vioxx was pulled from the market for safety concerns, an FDA panel gave the testosterone patch - made by
'"/>




Page: 1 2 3

Related medicine news :

1. The Use Of Antioxidants To Diminish Effects of Alcohol During Pregnancy Questioned
2. Arithmetic Skills Found To Diminish With Progression Of Alzheimer’s Disease
3. Soldiers Returning From Iraq Suffer From Diminished Mental Functioning
4. Diminishing Differences and Empowering Eves
5. High Hopes Pinned At Hungarian Bird Flu Vaccine
6. Hearing May Be Regained: Research Provides Hopes
7. India Hopes to Become Free of Bird Flu Soon
8. By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment
9. Effective Strategy Against Bird flu-Spainish Flu Vaccine Raises Hopes
10. Canadian Researchers Raise Hopes of Treatment for Memory Loss
11. Earth Day Celebrated With Hopes of a Greener Tomorrow

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA Diminish Hopes Viagra

(Date:11/7/2009)... October 23-25th marked the ...nd celebrities fighting the battle against pediatr...he foundation and it,s efforts for many years. , ...s) November 7, 2009 -- The weekend of October 23-2...ther anglers and celebrities fighting the battle a...
(Date:11/6/2009)...LANTA, Nov. 6 Recently a Narconon of Georgia grad...xperience with prescription drug abuse. The specia...ption drug addiction . In the report Andrew sh... more should be done to prevent prescription drug ...ing I knew I opened my eyes to my father on top of...
(Date:11/6/2009)...OTTSDALE, Ariz., Nov. 6 Healthcare Trust of Ameri... real estate investment trust, announced the execu...ent") to acquire a medical office building located...000. ,, The Hampden Place Medical Center is locat...ented, mixed-use redevelopment district. Hampden P...
(Date:11/6/2009)...KE FOREST, Ill., Nov. 6 Hospira, Inc. (NYSE: HSP...medication delivery company, today announced that ... Annual Health Care Conference on Wednesday, Dec. ...cheduled to begin at 9:30 a.m. Eastern time on Wed... interested parties through a live audiocast acces...
(Date:11/6/2009)...t-term limitations seem to wane as years go by, re...y News) -- New research suggests that people with ...ears of developing the disease are more likely to ...han others with the condition. , The findings, pub...h the disease who relapse within five years of dev...
Breaking Medicine News(10 mins):Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 3Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 3Health News:Early Relapse of MS May Mean Fewer Issues Later 2
...urth Annual Physician On-Call Pay ...n, Cotter and Associates, Inc.,has published its f... and,practices, the 2008 Physician On-call Pay Sur...hysician specialty areas along,with data reported ...
...egins -, CORONA, Calif., July 25 Watson,Pharmace...harmaceutical,company, announced today that its su...Omeprazole Delayed-Release Capsules USP product in...ing the,first to file an ANDA containing a paragra...
..., Robert J. Reilly, Joins Aethon Team, PITTSBURGH...the leading developer of mobile robotics for,hospi...obert J. Reilly has,joined the company as Senior V...acy Division, brings more than 30,years of experie...
...f Companies will,showcase their unique line of can...iation of Physicists in Medicine (AAPM) annual mee... IMPAC and CMS are delivering,cutting-edge radiati...ian efficiency., "Our recent acquisition of CMS b...
...cs, Inc. today,announced that it has filed a regis...and Exchange Commission relating to the proposed i...ck. The number of shares of common,stock to be off... Securities Inc. is acting as sole book-running ma...
...ying to drop pounds, study finds , , FRIDA...ded Monday morning weigh-ins knows this unalterabl..., researchers have some science to back up dieters...es can wreak havoc on weight control, either causi...
Other Medicine News:Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
(Date:11/6/2009)..., BOTHELL, Wash., Nov. 6 ...inancial results for the three and nine months end...SCOLR Pharma,s President and CEO, said, "We contin... 12-hour ibuprofen formulation. Several potential ...ime, personnel and external resources as they eval...
(Date:11/6/2009)..., SAN DIEGO, Nov. 6 Trius Therapeu...istration statement on Form S-1 with the U.S. Secu... proposed initial public offering of shares of its...e sold in the offering will be offered by the Comp...cting as sole book-running manager, Piper Jaffray ...
(Date:11/6/2009)..., DETROIT, Nov. 6 Caraco...D ) has launched ketorolac tromethamine ophthalmic...e US Food and Drug Administration (FDA) for Sun Ph... generic Acular® ophthalmic solution on the f...h of ketorolac is therapeutically equivalent to Ac...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2LCA Applauds Senate Leadership Team Working to Secure New FDA Regulatory Authority Over Tobacco 47852 1LCA Applauds Senate Leadership Team Working to Secure New FDA Regulatory Authority Over Tobacco 47852 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 1U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 3InterMune to Present at Goldman Sachs Healthcare Conference 12456 1
...BUSINESS WIRE)-May 10, 2007--Today, the,New Englan...wo,Phase III studies of Merck,s cervical cancer va... (Types 6, 11, 16, 18),Recombinant Vaccine). In th...ction against cervical, vaginal and vulvar disease...d to protect,against, HPV types 6, 11, 16, and 18....
...May 11, 2007 /PRNewswire-FirstCall/ --,NicOx S.A. ...ase 2a,study for NCX 1000, which is covered by its... preliminary analysis of 11 patients,from this pro...ed,the safety profile of NCX 1000 but did not demo...nuation of this clinical trial. As a,consequence, ...
Other Medicine Technology:New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 2New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 3New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 5New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 6New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 7New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 8New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 9New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 10New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 11New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 12New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 13New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 14New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 15New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 16New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 17New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 18New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 19New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 20New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 21New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 22New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 23New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 24New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 25New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 26New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 27New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 28New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 29New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 30New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 31New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 32NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3
Lacoste Sun Collection
Bvlgari Vision Collection
Aristar Eyewear Collection
...r and style. Creativity and cutting-edge design. D...ompanies, signed a new licensing agreement in Octo...985 by the famous designer duo, Domenico Dolce and...r Mediterranean roots to create the distinguishing...
Medicine Products: